What's new? Log in Free sign up

Novo Nordisk A/S (NVO)

Company Profile

Company profile

Ticker

NVO, NONOF

Exchange

Website

www.novonordisk.com

CEO

Lars Fruergaard Jorgensen

Incorporated

Location

Fiscal year end

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Johnson & Johnson • Merck & Co. • AbbVie • Teva Pharmaceutical Industries Limited • Bausch Health Companies • Abbott Laboratories • Eli Lilly and • Bristol-Myers Squibb • Viatris ...

Former names

BEXY COMMUNICATIONS INC, CHENIERE ENERGY INC

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

NVO stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Average target

$57.83

Low target

$46.00

High target

$73.50

Latest filings (excl ownership)

View all

Current report (foreign)

Current report (foreign)

Current report (foreign)

Disclosure regarding Iran Threat Reduction and Syria Human Rights Act

Annual report (foreign)

Current report (foreign)

Current report (foreign)

Current report (foreign)

Current report (foreign)

Current report (foreign)

Latest ownership filings

View all

Innate Pharma SA

Annual report of employee stock purchases

Annual report of employee stock purchases

Innate Pharma SA

BlackRock, Inc.

Annual report of employee stock purchases

Annual report of employee stock purchases

Annual report of employee stock purchases

Annual report of employee stock purchases

Financial summary

Financial statements Chart NVO financial data

Quarter (USD)	Dec 25	Dec 24	Dec 23	Dec 22
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 25	Dec 24	Dec 23	Dec 22
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Institutional ownership, Q4 2024

NVO institutional ownership history Ownership history

7.6% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	1643	1774	-7.4%
Opened positions	202	150	+34.7%
Closed positions	333	226	+47.3%
Increased positions	587	694	-15.4%
Reduced positions	637	641	-0.6%

13F shares	Current	Prev Q	Change
Total value	26.46 tn	36.09 tn	-26.7%
Total shares	337.28 mm	334.59 mm	+0.8%
Total puts	10.51 mm	7.78 mm	+35.2%
Total calls	11.35 mm	4.94 mm	+129.9%
Total put/call ratio	0.9	1.6	-41.2%

Largest owners	Shares	Value	Change
Jennison Associates	19.94 mm	$1.72 tn	-1.2%
BAC Bank of America	15.49 mm	$1.33 tn	+8.1%
GQG Partners	12.99 mm	$1.12 tn	+74.7%
Fisher Asset Management	12.64 mm	$1.09 tn	-5.0%
MS Morgan Stanley	12.20 mm	$1.05 tn	-15.0%
Loomis Sayles & Co L P	11.57 mm	$995.40 mm	+34.2%
Fayez Sarofim & Co	11.38 mm	$979.29 bn	-6.8%
FMR	10.02 mm	$862.08 bn	-44.1%
Folketrygdfondet	8.90 mm	$765.92 bn	+0.5%
Renaissance Technologies	8.31 mm	$715.08 bn	+1.5%

Largest transactions	Shares	Bought/sold	Change
FMR	10.02 mm	-7.91 mm	-44.1%
GQG Partners	12.99 mm	+5.56 mm	+74.7%
RJF Raymond James Financial	4.71 mm	+4.71 mm	NEW
Raymond James & Associates	0.00	-3.53 mm	EXIT
T. Rowe Price	6.35 mm	-3.24 mm	-33.8%
Loomis Sayles & Co L P	11.57 mm	+2.95 mm	+34.2%
Nuveen Asset Management	6.24 mm	+2.64 mm	+73.2%
MS Morgan Stanley	12.20 mm	-2.16 mm	-15.0%
Two Sigma Investments	1.84 mm	+1.84 mm	NEW
International Assets Investment Management	19.91 k	-1.79 mm	-98.9%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.